BlackRock Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $243M | Sell |
1,987,406
-44,066
| -2% | -$5.39M | 0.12% | 215 |
|
|
2016
Q3 | $249M | Sell |
2,031,472
-3,823
| -0.2% | -$468K | 0.13% | 192 |
|
|
2016
Q2 | $238M | Sell |
2,035,295
-13,527
| -0.7% | -$1.58M | 0.12% | 191 |
|
|
2016
Q1 | $285M | Sell |
2,048,822
-381,110
| -16% | -$53.1M | 0.15% | 152 |
|
|
2015
Q4 | $464M | Sell |
2,429,932
-17,479
| -0.7% | -$3.33M | 0.26% | 80 |
|
|
2015
Q3 | $383M | Buy |
2,447,411
+105,757
| +5% | +$16.5M | 0.22% | 100 |
|
|
2015
Q2 | $423M | Buy |
2,341,654
+235,956
| +11% | +$42.7M | 0.23% | 97 |
|
|
2015
Q1 | $365M | Sell |
2,105,698
-24,768
| -1% | -$4.29M | 0.2% | 111 |
|
|
2014
Q4 | $394M | Buy |
2,130,466
+147,089
| +7% | +$27.2M | 0.21% | 105 |
|
|
2014
Q3 | $329M | Buy |
1,983,377
+23,059
| +1% | +$3.82M | 0.19% | 112 |
|
|
2014
Q2 | $306M | Buy |
1,960,318
+115,407
| +6% | +$18M | 0.18% | 128 |
|
|
2014
Q1 | $281M | Buy |
1,844,911
+358,961
| +24% | +$54.6M | 0.18% | 133 |
|
|
2013
Q4 | $197M | Buy |
1,485,950
+59,271
| +4% | +$7.88M | 0.13% | 178 |
|
|
2013
Q3 | $166M | Sell |
1,426,679
-5,074
| -0.4% | -$589K | 0.11% | 205 |
|
|
2013
Q2 | $132M | Buy |
+1,431,753
| New | +$132M | 0.1% | 235 |
|